These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19932448)

  • 1. Photoantimicrobials--so what's stopping us?
    Wainwright M
    Photodiagnosis Photodyn Ther; 2009; 6(3-4):167-9. PubMed ID: 19932448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photoantimicrobials-are we afraid of the light?
    Wainwright M; Maisch T; Nonell S; Plaetzer K; Almeida A; Tegos GP; Hamblin MR
    Lancet Infect Dis; 2017 Feb; 17(2):e49-e55. PubMed ID: 27884621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in developing new antibacterial drugs.
    Williams KJ; Bax RP
    Curr Opin Investig Drugs; 2009 Feb; 10(2):157-63. PubMed ID: 19197793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Safe' photoantimicrobials for skin and soft-tissue infections.
    Wainwright M
    Int J Antimicrob Agents; 2010 Jul; 36(1):14-8. PubMed ID: 20382003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The forgotten Gram-negative bacilli: what genetic determinants are telling us about the spread of antibiotic resistance.
    Gootz TD
    Biochem Pharmacol; 2006 Mar; 71(7):1073-84. PubMed ID: 16359640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's new on the antimicrobial horizon?
    Song JH
    Int J Antimicrob Agents; 2008 Dec; 32 Suppl 4():S207-13. PubMed ID: 19134521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful, multiresistant bacterial clones.
    Woodford N
    J Antimicrob Chemother; 2008 Feb; 61(2):233-4. PubMed ID: 18077310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tigecycline.
    Pankey GA
    J Antimicrob Chemother; 2005 Sep; 56(3):470-80. PubMed ID: 16040625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unmet medical needs in antibacterial therapy.
    Rice LB
    Biochem Pharmacol; 2006 Mar; 71(7):991-5. PubMed ID: 16280121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in antibacterial therapy against emerging bacterial pathogens.
    Pournaras S; Iosifidis E; Roilides E
    Semin Hematol; 2009 Jul; 46(3):198-211. PubMed ID: 19549574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of genomics to select antibacterial targets.
    Pucci MJ
    Biochem Pharmacol; 2006 Mar; 71(7):1066-72. PubMed ID: 16412986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial pressure and the emergence and spread of multiresistant enterococci.
    Rice LB
    Postgrad Med; 2001 Feb; 109(2 Suppl):22-31. PubMed ID: 19667554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic effect of lanthanide derivatives of meso-tetra(N-methyl-4-pyridyl)porphine against Staphylococcus aureus.
    Jurczak A; Szramka B; Grinholc M; Legendziewicz J; Bielawski KP
    Acta Biochim Pol; 2008; 55(3):581-5. PubMed ID: 18726009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance uncovers the smoking gun for resistance emergence.
    Verhoef J; Fluit A
    Biochem Pharmacol; 2006 Mar; 71(7):1036-41. PubMed ID: 16288993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial resistance and study of new antibiotics].
    Xiao CL; Yao TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):351-3. PubMed ID: 15379254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The fast track to multidrug resistance.
    Kaufmann BB; Hung DT
    Mol Cell; 2010 Feb; 37(3):297-8. PubMed ID: 20159549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.
    Rouveix B
    J Antimicrob Chemother; 2007 Jun; 59(6):1208-9. PubMed ID: 17507420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.